Wolverine Trading’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $113M | Buy |
505,100
+14,900
| +3% | +$3.03M | 0.08% | 164 |
|
|
2025
Q2 | $89.4M | Buy |
+490,200
| New | +$91.1M | 0.09% | 150 |
|
|
2025
Q1 | – | Sell |
-592,700
| Closed | -$104M | – | 4627 |
|
|
2024
Q4 | $104M | Sell |
592,700
-19,700
| -3% | -$3.62M | 0.1% | 112 |
|
|
2024
Q3 | $119M | Buy |
612,400
+28,000
| +5% | +$5.23M | 0.13% | 90 |
|
|
2024
Q2 | $100M | Buy |
584,400
+62,800
| +12% | +$10.4M | 0.11% | 101 |
|
|
2024
Q1 | $95M | Buy |
521,600
+2,700
| +0.5% | +$465K | 0.1% | 107 |
|
|
2023
Q4 | $80.4M | Buy |
518,900
+82,100
| +19% | +$12M | 0.08% | 123 |
|
|
2023
Q3 | $65.1M | Sell |
436,800
-199,900
| -31% | -$29.3M | 0.07% | 121 |
|
|
2023
Q2 | $84.8M | Buy |
636,700
+157,400
| +33% | +$23.1M | 0.1% | 92 |
|
|
2023
Q1 | $75.7M | Buy |
479,300
+105,000
| +28% | +$16.1M | 0.12% | 92 |
|
|
2022
Q4 | $60.5M | Buy |
374,300
+156,500
| +72% | +$24M | 0.09% | 164 |
|
|
2022
Q3 | $31.1M | Sell |
217,800
-52,900
| -20% | -$7.59M | 0.05% | 211 |
|
|
2022
Q2 | $41.7M | Sell |
270,700
-67,200
| -20% | -$10.3M | 0.07% | 149 |
|
|
2022
Q1 | $55.3M | Sell |
337,900
-232,200
| -41% | -$33.7M | 0.07% | 160 |
|
|
2021
Q4 | $77.5M | Buy |
570,100
+37,400
| +7% | +$4.42M | 0.09% | 137 |
|
|
2021
Q3 | $58M | Buy |
532,700
+98,300
| +23% | +$11.2M | 0.07% | 196 |
|
|
2021
Q2 | $48.8M | Buy |
434,400
+99,300
| +30% | +$11.2M | 0.08% | 192 |
|
|
2021
Q1 | $35.8M | Buy |
335,100
+58,500
| +21% | +$6.26M | 0.05% | 244 |
|
|
2020
Q4 | $29.1M | Buy |
276,600
+46,300
| +20% | +$4.45M | 0.05% | 280 |
|
|
2020
Q3 | $20M | Sell |
230,300
-83,700
| -27% | -$7.88M | 0.05% | 299 |
|
|
2020
Q2 | $30.3M | Sell |
314,000
-79,900
| -20% | -$7.03M | 0.08% | 155 |
|
|
2020
Q1 | $29.6M | Buy |
393,900
+84,100
| +27% | +$7.16M | 0.09% | 146 |
|
|
2019
Q4 | $27.4M | Sell |
309,800
-33,900
| -10% | -$2.81M | 0.07% | 247 |
|
|
2019
Q3 | $25.7M | Buy |
343,700
+33,100
| +11% | +$2.27M | 0.07% | 208 |
|
|
2019
Q2 | $22.6M | Sell |
310,600
-36,600
| -11% | -$2.88M | 0.06% | 254 |
|
|
2019
Q1 | $28M | Buy |
347,200
+22,600
| +7% | +$1.85M | 0.08% | 183 |
|
|
2018
Q4 | $29.6M | Buy |
324,600
+73,000
| +29% | +$6.42M | 0.08% | 160 |
|
|
2018
Q3 | $23.8M | Sell |
251,600
-47,000
| -16% | -$4.46M | 0.05% | 254 |
|
|
2018
Q2 | $28.3M | Hold |
298,600
| – | – | 0.07% | 178 |
|
|
2018
Q1 | $28.3M | Sell |
298,600
-400
| -0.1% | -$43.9K | 0.07% | 178 |
|
|
2017
Q4 | $28.9M | Buy |
+299,000
| New | +$28.2M | 0.1% | 162 |
|
|
2017
Q2 | – | Sell |
-251,700
| Closed | -$16.5M | – | 4182 |
|
|
2017
Q1 | $16.5M | Sell |
251,700
-44,000
| -15% | -$2.77M | 0.09% | 229 |
|
|
2016
Q4 | $18.5M | Buy |
295,700
+84,900
| +40% | +$5.18M | 0.09% | 225 |
|
|
2016
Q3 | $13.2M | Buy |
210,800
+28,300
| +16% | +$1.83M | 0.06% | 357 |
|
|
2016
Q2 | $11.3M | Buy |
+182,500
| New | +$11.1M | 0.06% | 316 |
|
Other funds holding ABBV
Wolverine Trading's ABBV Position: Q3 2025 in Review
Wolverine Trading reduced its AbbVie (ABBV) stake by 58% in Q3 2025, selling an estimated $1.23M and leaving 4,298 shares worth $959K. The position accounts for ﹤0.01% of the portfolio, ranked #2946.
Wolverine Trading first reported a position in ABBV in Q2 2016 and has held it in 33 quarters since. The position peaked at $132M in Q4 2022. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.
- Wolverine Trading held 4,298 shares of AbbVie worth $959K as of Q3 2025.
- Wolverine Trading sold 6,058 AbbVie shares in Q3 2025, an estimated $1.23M.
- AbbVie made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2946 holding.
- Wolverine Trading first reported a position in AbbVie in Q2 2016 and has held it in 33 quarters since.
- Wolverine Trading's AbbVie position peaked at $132M in Q4 2022.
- 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.